Berylson Capital Partners’s Ascendis Pharma ASND Stock Holding History
Bought
Maintained
Sold
Other funds holding ASND
Berylson Capital Partners's ASND Position: Q3 2024 in Review
Berylson Capital Partners held its Ascendis Pharma (ASND) position steady in Q3 2024 at 1,900 shares worth $284K. The position accounts for 0.69% of the portfolio, ranked #20.
Berylson Capital Partners first reported a position in ASND in Q1 2019 and has held it in 15 quarters since. The position peaked at $12.1M in Q4 2020. 219 funds tracked by Wall St. Rank hold ASND as of Q3 2024.
- Berylson Capital Partners held 1,900 shares of Ascendis Pharma worth $284K as of Q3 2024.
- Berylson Capital Partners left its Ascendis Pharma share count unchanged in Q3 2024.
- Ascendis Pharma made up 0.69% of Berylson Capital Partners's portfolio in Q3 2024, its #20 holding.
- Berylson Capital Partners first reported a position in Ascendis Pharma in Q1 2019 and has held it in 15 quarters since.
- Berylson Capital Partners's Ascendis Pharma position peaked at $12.1M in Q4 2020.
- 219 funds tracked by Wall St. Rank held Ascendis Pharma as of Q3 2024.
Based on Berylson Capital Partners's 13F filing for Q3 2024, filed 14 Nov 2024.